eticlopride has been researched along with Anochlesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izzo, E; Koob, GF; Sanna, PP | 1 |
| Fowler, SC; Liou, JR | 1 |
2 other study(ies) available for eticlopride and Anochlesia
| Article | Year |
|---|---|
Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Corticotropin-Releasing Hormone; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Injections, Intraventricular; Male; Mice; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior; Time Factors | 2005 |
Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
Topics: Animals; Antipsychotic Agents; Benzazepines; Catalepsy; Clozapine; Conditioning, Operant; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |